Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition